These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31660880)

  • 1. Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review.
    De la Cruz-Cano E; Jiménez-González CDC; Morales-García V; Pineda-Pérez C; Tejas-Juárez JG; Rendón-Gandarilla FJ; Jiménez-Morales S; Díaz-Gandarilla JA
    BMC Nephrol; 2019 Oct; 20(1):393. PubMed ID: 31660880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus.
    Zhang R; Zhuang L; Li M; Zhang J; Zhao W; Ge X; Chen Y; Wang F; Wang N; Bao Y; Liu L; Liu Y; Jia W
    Mol Cell Biochem; 2018 Jan; 437(1-2):203-210. PubMed ID: 28744814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes.
    Ng DP; Nurbaya S; Choo S; Koh D; Chia KS; Krolewski AS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2260-4. PubMed ID: 18263927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biological effects of sodium-chloride cotransporter (SLC12A3) in diabetic nephropathy.
    Abu Seman N; He B; Ojala JR; Wan Mohamud WN; Östenson CG; Brismar K; Gu HF
    Am J Nephrol; 2014; 40(5):408-16. PubMed ID: 25401745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.
    Kim JH; Shin HD; Park BL; Moon MK; Cho YM; Hwang YH; Oh KW; Kim SY; Lee HK; Ahn C; Park KS
    Diabetes; 2006 Mar; 55(3):843-8. PubMed ID: 16505253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report.
    Liu Z; Wang S; Zhang R; Wang C; Lu J; Shao L
    BMC Med Genomics; 2021 Aug; 14(1):198. PubMed ID: 34348722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and Biological Effects of
    Li N; Gu HF
    Front Genet; 2022; 13():799224. PubMed ID: 35591852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome.
    Lee JW; Lee J; Heo NJ; Cheong HI; Han JS
    J Korean Med Sci; 2016 Jan; 31(1):47-54. PubMed ID: 26770037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SLC12A3 gene mutations and clinical characteristics in two pedigrees with Gitelman syndrome.
    Ying Q; Ye Z; Zhang W; Pan Y; Dai L; Lin K; Feng X; Dong X; He F
    Clin Endocrinol (Oxf); 2023 Nov; 99(5):474-480. PubMed ID: 36562655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report.
    Subasinghe CJ; Sirisena ND; Herath C; Berge KE; Leren TP; Bulugahapitiya U; Dissanayake VHW
    BMC Nephrol; 2017 Apr; 18(1):140. PubMed ID: 28446151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION.
    Liu S; Ke J; Zhang B; Yu C; Feng Y; Zhao D
    Endocr Pract; 2018 Oct; 24(10):889-893. PubMed ID: 30084681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemia: A case report.
    He G; Gang X; Sun Z; Wang P; Wang G; Guo W
    Medicine (Baltimore); 2020 Jul; 99(29):e21123. PubMed ID: 32702863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation.
    Tseng MH; Yang SS; Hsu YJ; Fang YW; Wu CJ; Tsai JD; Hwang DY; Lin SH
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1478-82. PubMed ID: 22679066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine.
    Luo JW; Meng XR; Yang X; Liang JX; Hong FY; Zheng XY; Li WH
    Chin J Integr Med; 2017 Jun; 23(6):461-468. PubMed ID: 26825084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes.
    Yadav AK; Kumar V; Dutta P; Bhansali A; Jha V
    J Diabetes; 2014 Nov; 6(6):547-55. PubMed ID: 24433479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms.
    Tanaka N; Babazono T; Saito S; Sekine A; Tsunoda T; Haneda M; Tanaka Y; Fujioka T; Kaku K; Kawamori R; Kikkawa R; Iwamoto Y; Nakamura Y; Maeda S
    Diabetes; 2003 Nov; 52(11):2848-53. PubMed ID: 14578305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel SLC12A3 homozygous c2039delG mutation in Gitelman syndrome with hypocalcemia.
    Yang W; Zhao S; Xie Y; Mo Z
    BMC Nephrol; 2018 Dec; 19(1):362. PubMed ID: 30558554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gitelman syndrome with a novel frameshift variant in SLC12A3 gene accompanied by chronic kidney disease and type 2 diabetes mellitus.
    Iio K; Mori T; Bessho S; Imai Y; Hatanaka M; Omori H; Kouhara H; Chiga M; Sohara E; Uchida S; Kaimori JY
    CEN Case Rep; 2022 May; 11(2):191-195. PubMed ID: 34617250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous
    Zhang JH; Ruan DD; Hu YN; Ruan XL; Zhu YB; Yang X; Wu JB; Lin XF; Luo JW; Tang FQ
    Biomed Res Int; 2021; 2021():9973161. PubMed ID: 34046503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in Genetics and Epigenetics Research on Diabetic Nephropathy in Malaysia.
    Abu Seman N; Othman SH
    J Diabetes Res; 2023; 2023():9053580. PubMed ID: 37187702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.